Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests simple parenting programs to stop baby obesity before it starts

NCT ID NCT06719102

Prevention Sponsor: University of Texas at Austin Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests two parenting programs for families with newborns. One program teaches parents how to recognize baby hunger and fullness cues and offers nutrition advice. The other provides safety tips like safe sleep and car seat use. Researchers will track the babies' growth and eating habits to see if the feeding program helps prevent obesity. About 266 families in Austin will take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
behavioral intervention (responsive feeding coaching and safety education)
What this could lead to
If successful, this could provide a simple, scalable way for parents to help prevent childhood obesity and promote healthy eating habits from infancy.
What could go wrong
This is an early-stage efficacy trial with a moderate sample size. Results may not apply to all families, and behavioral changes can be hard to maintain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 266 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

0 to 90 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * A singleton infant 3-9 weeks of age, born ≥37 weeks gestation. * The mother and other caregiver must be at least 18 years of age. * The infant must live with the mother. * Lives within the Austin metropolitan area. * English or Spanish speaking. * The primary caregiver must identify as the mother. Exclusion Criteria: * Infant diagnosed with major physical disabilities and/or medical condition that affects feeding and growth, and/or born \<37 weeks gestation. * Infant experienced NICU stay \>7 days. * Twins, triplets, or other multiples. * Mothers and/or other caregivers younger than 18 years old. * Mothers that do not consent to being video recorded with their baby. * Families that do not speak either English or Spanish will be excluded from this study. Families that only speak English or Spanish, or families that speak English or Spanish and another language, will be accepted. * Do not plan to remain in Austin area for the next two years.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Childhood obesity prevention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

obesity disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Childhood obesity prevention Infant growth Parenting behavior

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dell Pediatric Research Institute

    RECRUITING

    Austin, Texas, 78723, United States

  • Sarah M. & Charles E. Seay Building

    NOT_YET_RECRUITING

    Austin, Texas, 78712, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.